Roche blood test could help personalize cancer immunotherapy Ruby Khatun Khatun10 Sept 2017 10:01 AM ISTMADRID: A new blood test from Roche and Foundation Medicine has shown it can accurately measure the number of mutations within a tumor, potentially...
Mercks immunotherapy, chemo mix shows extended lung cancer gains Ruby Khatun Khatun10 Sept 2017 9:45 AM ISTMADRID: Giving Merck & Co’s immunotherapy drug Keytruda in combination with chemotherapy for previously untreated advanced lung cancer appears to...
Johnson and Johnson India unveils enhanced paternity leave Ruby Khatun Khatun10 Sept 2017 9:34 AM ISTNew Delhi: Johnson and Johnson India on Wednesday announced an enhanced paternity leave policy under which new and adoptive fathers will be entitled...
Merck to acquire Rigontec, RIG-I therapeutics pioneer, advancing leadership in Immuno-Oncology Ruby Khatun Khatun9 Sept 2017 9:57 AM ISTKENILWORTH, N.J. & MUNICH: Merck, known as MSD outside the United States and Canada, and Rigontec announced that Merck will acquire...
Dr Reddys Vizag unit gets 6 observations by German regulator Ruby Khatun Khatun9 Sept 2017 9:32 AM ISTNew Delhi: Dr Reddy's Laboratories (DRL) said the German drug regulator has concluded the audit of its Visakhapatnam formulations facility with six...
GSK bets on pioneering cancer therapy with Adaptimmune deal Ruby Khatun Khatun9 Sept 2017 9:32 AM ISTLONDON: GlaxoSmithKline (GSK) said it has licensed the rights to Adaptimmune's pioneering T-cell therapy program to boost its pipeline in oncology,...
Eisai signs agreement with Merck to expand enrollment of combination study for Lenvima and Pembrolizumab Ruby Khatun Khatun8 Sept 2017 1:28 PM ISTTOKYO: Eisai Co., Ltd. has announced that it has signed an agreement with Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside of the...
Cadila Moraiya plant successfully completes USFDA inspection Ruby Khatun Khatun8 Sept 2017 1:22 PM ISTNew Delhi: Drug firm Cadila Healthcare on Thursday said the US health regulator has issued no observations after completion of inspection of its...
Cipla promoters, relatives get into share transfer agreement Ruby Khatun Khatun8 Sept 2017 1:21 PM ISTNew Delhi: Drug firm Cipla said some of its promoters and promoter group along with their relatives have entered into an agreement on the transfer of...
Pharma firm face charges of cheating SBI of Rs 157 crore Ruby Khatun Khatun7 Sept 2017 4:26 PM ISTCHANDIGARH: A Judicial Magistrate court in Chandigarh has framed charges against the directors and managers of Surya Pharmaceuticals Limited of...
Dr Reddys launches antidepressant, muscle relaxant tablets in US Ruby Khatun Khatun7 Sept 2017 11:19 AM ISTNew Delhi: Dr. Reddy's Laboratories on Wednesday said it has launched Bupropion Hydrochloride extended-release tablets used in treating a major...
Novo Nordisk settles US probe over diabetes drug for nearly 58.7 million dollar Ruby Khatun Khatun7 Sept 2017 10:48 AM ISTNovo Nordisk will pay nearly $58.7 million to resolve claims the drugmaker's sales staff downplayed the importance of U.S. Food and Drug...
